General

Financials

People

Activity

Dyax

Company

date founded

Financing round

General

About Company

Dyax Corp. is a biopharmaceutical company that develops and commercializes biotherapeutics for unmet medical needs.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.1989

founders

Number of employees

Company Type

For Profit

IPO status

Private

Description

The Company's commercialization of KALBITOR is done independently in the United States, and it has collaborations with other pharmaceutical companies to develop DX-88 for other medical conditions, such as reducing blood loss during surgery and treating retinal diseases.

Contacts

location

Cambridge, MA, USA

Contact Email

[email protected]

Phone number

Website URL

http://www.dyax.com

Social url

Similar Companies
1000

Conatus Pharmaceuticals

Conatus PharmaceuticalsConatus Pharmaceuticals is a biotechnology company focused on developing and commercializing innovative medicines to treat chronic diseases.

Dantari

DantariDantari is a biotechnology company that develops breakthrough medicines for cancer and other serious diseases.

Cephalon

CephalonTeva Pharmaceuticals is a global pharmaceutical company that develops and sells affordable generic drugs.

Acceleron Pharma

Acceleron PharmaAcceleron Pharma develops and sells biotherapeutics for musculoskeletal, metabolic, and cancer diseases.

M&A Details
1

Transaction name

Acquired by Shire

Acquired by

Shire

announced date

02.11.2015

price

$5.9B

Financials

Co-Investors

People

Founders
1

Employee Profiles
6

Gustav A. Christensen

President and CEO

Steve Bernitz

Sr. positions - Business Development, Alliance Management & Product Development

Activity

Recent News
0